Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Freshpet faces federal securities investigation over dog food 'human grade' claims.

Market News
22 May 2026
GlobeNewsWire
View Source
Bearish
pluang ai news

Freshpet Inc. is under investigation by law firm Lowey Dannenberg for potential violations of federal securities laws related to its dog food marketing claims. The BBB National Programs' National Advertising Division found some claims valid but recommended discontinuing the 'human grade' claim, which Freshpet agreed to do. The investigation focuses on whether Freshpet and its executives provided accurate and complete information to investors. Investors who suffered losses over $50,000 are encouraged to contact the law firm for possible legal action.

More News

Grindr rejects $18/share takeover bid, citing strong growth and raised 2026 revenue guidance.

Grindr rejects $18/share takeover bid, citing strong growth and raised 2026 revenue guidance.

Grindr's board has rejected a takeover offer of $18 per share, believing it undervalues the company's growth prospects. Despite a slowdown in competitors like Match Group and Bumble, Grindr continues to grow revenue by over 30% year-over-year. The co...

Market News
Bullish
4 hours ago
Navios Maritime rated Buy on strong earnings, fleet growth, and 56% NAV discount offering upside.

Navios Maritime rated Buy on strong earnings, fleet growth, and 56% NAV discount offering upside.

Navios Maritime (NMM) is rated Buy due to its strong earnings, organic growth, and a significant 56% discount to net asset value (NAV). The company operates a diversified fleet of 149 vessels across dry bulk, containerships, and tankers, maintaining ...

Analyst Insights
Bullish
4 hours ago
Investigation launched over Regeneron’s optimistic trial claims that preceded stock drop.

Investigation launched over Regeneron’s optimistic trial claims that preceded stock drop.

Levi & Korsinsky has started an investigation into Regeneron Pharmaceuticals for potentially misleading investors about the results of a clinical trial. In March 2026, Regeneron's investor relations VP expressed hope for positive trial outcomes of a ...

Market News
Bearish
4 hours ago
Investigation launched into Prestige Consumer Healthcare over missed earnings and undisclosed acquisition

Investigation launched into Prestige Consumer Healthcare over missed earnings and undisclosed acquisition

Levi & Korsinsky has started an investigation into Prestige Consumer Healthcare following the company's failure to meet its Q4 and full-year financial projections, including adjusted gross margin, free cash flow, and adjusted EPS. Additionally, Prest...

Market News
Bearish
5 hours ago
Investigation launched into TriSalus Life Sciences after Q1 revenue misses estimates and cuts full-year guidance

Investigation launched into TriSalus Life Sciences after Q1 revenue misses estimates and cuts full-year guidance

Levi & Korsinsky has started an investigation into TriSalus Life Sciences following the company's Q1 2026 revenue of $8.9 million, which missed Wall Street's $9.4 million estimate. The company also lowered its full-year 2026 revenue forecast to $54 m...

Market News
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App